Thal, Switzerland

Jörg Schmitt

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 10.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Gaienhofen, DE (2016)
  • Gaienhofen, CH (2016)
  • Thal, CH (2006 - 2018)

Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Jörg Schmitt: Innovator in Iron Complex Compounds

Introduction

Jörg Schmitt, a distinguished inventor based in Thal, Switzerland, has made significant contributions to the field of pharmaceutical sciences. With a total of seven patents to his name, Schmitt is renowned for his innovative research and inventions aimed at addressing iron deficiency ailments.

Latest Patents

Among his recent achievements, Schmitt has developed patents focusing on iron(III) complex compounds that serve as effective treatments for iron deficiency symptoms and iron deficiency anemias. These patents outline pharmaceutical compositions that utilize these complexes as medicaments, particularly useful in both the treatment and prophylaxis of related health issues. His work in this area has the potential to benefit countless individuals suffering from these conditions.

Career Highlights

Throughout his career, Jörg Schmitt has collaborated with several prominent firms, including Vifor Pharma and Biosynthema Inc. His role in these organizations has propelled advances in the development of iron-related therapeutic solutions. Schmitt's expertise in this niche has established him as a notable figure within the pharmaceutical innovation landscape.

Collaborations

Jörg Schmitt has had the privilege to work alongside talented professionals such as Thomas Bark and Wilm Buhr. These collaborations have been instrumental in enriching his research endeavors and fostering innovative solutions within the medicinal chemistry domain. The synergy among these experts has undoubtedly facilitated the progress of their collective work.

Conclusion

In summary, Jörg Schmitt's contributions to the development of iron complex compounds represent a significant advancement in treating iron deficiency conditions. His dedication to innovation, combined with his collaborative spirit, positions him as an influential inventor in the pharmaceutical industry. Schmitt's work continues to pave the way for future innovations that can effectively combat iron deficiency anemia, ultimately improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…